Yamamoto, T.; Miyoshi, H.; Kakizaki, F.; Maekawa, H.; Yamaura, T.; Morimoto, T.; Katayama, T.; Kawada, K.; Sakai, Y.; Taketo, M.M.
Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients with Potential Benefit from FGFR Inhibitor Therapy. Cancers 2020, 12, 2010.
https://doi.org/10.3390/cancers12082010
AMA Style
Yamamoto T, Miyoshi H, Kakizaki F, Maekawa H, Yamaura T, Morimoto T, Katayama T, Kawada K, Sakai Y, Taketo MM.
Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients with Potential Benefit from FGFR Inhibitor Therapy. Cancers. 2020; 12(8):2010.
https://doi.org/10.3390/cancers12082010
Chicago/Turabian Style
Yamamoto, Takehito, Hiroyuki Miyoshi, Fumihiko Kakizaki, Hisatsugu Maekawa, Tadayoshi Yamaura, Tomonori Morimoto, Toshiro Katayama, Kenji Kawada, Yoshiharu Sakai, and M. Mark Taketo.
2020. "Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients with Potential Benefit from FGFR Inhibitor Therapy" Cancers 12, no. 8: 2010.
https://doi.org/10.3390/cancers12082010
APA Style
Yamamoto, T., Miyoshi, H., Kakizaki, F., Maekawa, H., Yamaura, T., Morimoto, T., Katayama, T., Kawada, K., Sakai, Y., & Taketo, M. M.
(2020). Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients with Potential Benefit from FGFR Inhibitor Therapy. Cancers, 12(8), 2010.
https://doi.org/10.3390/cancers12082010